p.43 抽出テキスト

the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study. Eur Heart J 2017; 38: 3124-3134. PMID: 29020367 112. Fearon WF, Bornschein B, Tonino PA, et al. Fractional Flow Reserve Versus Angiography  for Multivessel Evaluation (FAME) Study Investigators. Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation 2010; 122: 2545-2550. PMID: 21126973 113. Fearon WF, Nishi T, De Bruyne B, et al. FAME 2 Trial Investigators. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). Circulation 2018; 137: 480-487. PMID: 29097450 114. Yu W, Tanigaki T, Ding D, et al. Accuracy of Intravascular Ultrasound-Based Fractional Flow Reserve in Identifying Hemodynamic Significance of Coronary Stenosis. Circ Cardiovasc Interv 2021; 14: e009840. PMID: 33541105 115. Collet C, Onuma Y, Sonck J, et al. Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis. Eur Heart J 2018; 39: 3314-3321. PMID: 30137305 116. Tu S, Westra J, Adjedj J, et al. Fractional flow reserve in clinical practice: from wire-based invasive measurement to image-based computation. Eur Heart J 2020; 41: 3271-3279. PMID: 31886479 117. Huang J, Emori H, Ding D, et al. Diagnostic performance of intracoronary optical coherence tomography-based versus angiography-based fractional flow reserve for the evaluation of coronary lesions. EuroIntervention 2020; 16: 568-576. PMID: 31951207 118. Davies JE, Sen S, Dehbi HM, et al. Use of the Instantaneous Wavefree Ratio or Fractional Flow Reserve in PCI. N Engl J Med 2017; 376: 1824-1834. PMID: 28317458 119. Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR-SWE- DEHEART Investigators. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med 2017; 376: 1813-1823. PMID: 28317438 120. Lee JM, Choi KH, Park J, et al. Physiological and Clinical Assessment of Resting Physiological Indexes. Resting Full-Cycle Ratio, Diastolic Pressure Ratio, and Instantaneous Wave-Free Ratio. Circulation 2019; 139: 889-900. PMID: 30586749 121. Van’t Veer M, Pijls NHJ, Hennigan B, et al. Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? J Am Coll Cardiol 2017; 70: 3088-3096. PMID: 29268922 122. Petraco R, Escaned J, Sen S, et al. Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry. EuroIntervention 2013; 9: 91-101. PMID: 22917666 123. Berry C, van ‘t Veer M, Witt N, et al. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): A multicenter study in consecutive patients. J Am Coll Cardiol 2013; 61: 1421-1427. PMID: 23395076 124. Lee JM, Rhee TM, Choi KH, et al. Clinical Outcome of Lesions With Discordant Results Among Different Invasive Physiologic Indices - Resting Distal Coronary to Aortic Pressure Ratio, Resting Full-Cycle Ratio, Diastolic Pressure Ratio, Instantaneous Wave-Free Ratio, and Fractional Flow Reserve. Circ J 2019; 83: 2210-2221. PMID: 31484836 125. Lee JM, Lee SH, Hwang D, et al. Long-Term Clinical Outcomes of Nonhyperemic Pressure Ratios: Resting Full-Cycle Ratio, Diastolic Pressure Ratio, and Instantaneous Wave-Free Ratio. J Am Heart Assoc 2020; 9: e016818. PMID: 32914672 126. Wada T, Shiono Y, Kubo T, et al. Impact of instantaneous wave-free ratio on graft failure after coronary artery bypass graft surgery. Int J Cardiol 2021; 324: 23-29. PMID: 32966833 127. Andell P, Berntorp K, Christiansen EH, et al. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial. JACC Cardiovasc Interv 2018; 11: 2084-2094. PMID: 30336812 128. Warisawa T, Cook CM, Rajkumar C, et al. Safety of Revascularization Deferral of Left Main Stenosis Based on Instantaneous Wave- Free Ratio Evaluation. JACC Cardiovasc Interv 2020; 13: 1655- 1664. PMID: 32417088 129. Goto R, Takashima H, Ohashi H, et al. Independent predictors of

discordance between the resting full-cycle ratio and fractional flow reserve. Heart Vessels 2021; 36: 790-798. PMID: 33398440 130. Lee JM, Shin ES, Nam CW, et al. Discrepancy between fractional

flow reserve and instantaneous wave-free ratio: Clinical and angiographic characteristics. Int J Cardiol 2017; 245: 63-68. PMID: 28789845 131. Kato Y, Dohi T, Chikata Y, et al. Predictors of discordance between fractional flow reserve and resting full-cycle ratio in patients with coronary artery disease: Evidence from clinical practice. J Cardiol 2021; 77: 313-319. PMID: 33234404 132. Lee JM, Shin ES, Nam CW, et al. Clinical Outcomes According to Fractional Flow Reserve or Instantaneous Wave-Free Ratio in Deferred Lesions. JACC Cardiovasc Interv 2017; 10: 2502-2510. PMID: 29198458 133. Lee SH, Choi KH, Lee JM, et al. Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR. JACC Cardiovasc Interv 2019; 12: 2018-2031. PMID: 31563683 134. Hwang D, Jeon KH, Lee JM, et al. Diagnostic Performance of Resting and Hyperemic Invasive Physiological Indices to Define Myocardial Ischemia: Validation With 13N-Ammonia Positron Emission Tomography. JACC Cardiovasc Interv 2017; 10: 751-760. PMID: 28365268 135. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708. PMID: 8637515 136. Kikuta Y, Cook CM, Sharp ASP, et al. Pre-angioplasty instantaneous wave-free ratio pullback predicts hemodynamic outcome in humans with coronary artery disease: Primary results of the international multicenter iFR GRADIENT registry. JACC Cardiovasc Interv 2018; 11: 757-767. PMID: 29673507 137. Collet C, Sonck J, Vandeloo B, et al. Measurement of hyperemic pullback pressure gradients to characterize patterns of coronary atherosclerosis. J Am Coll Cardiol 2019; 74: 1772-1784. PMID: 31582137 138. Jeremias A, Davies JE, Maehara A, et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary intervention: The DEFINE PCI study. JACC Cardiovasc Interv 2019; 12: 1991-2001. PMID: 31648761 139. Niimi N, Sawano M, Ikemura N, et al. Applicability and Eligibility of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) for Patients who Underwent Revascularization with Percutaneous Coronary Intervention. J Clin Med 2020; 9: 2889. PMID: 32906673 140. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stressrest myocardial perfusion scintigraphy. Eur Heart J 2011; 32: 1012- 1024. PMID: 21258084 141. Shaw LJ, Berman DS, Maron DJ, et al. COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-1291. PMID: 18268144 142. Boden WE, O’Rourke RA, Teo KK, et al. COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516. PMID: 17387127 143. Sedlis SP, Hartigan PM, Teo KK, et al. COURAGE Trial Investigators. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. N Engl J Med 2015; 373: 1937-1946. PMID: 26559572 144. Chaitman BR, Alexander KP, Cyr DD, et al. ISCHEMIA Research Group. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation 2021; 143: 790-804. PMID: 33267610 145. Navarese EP, Lansky AJ, Kereiakes DJ, et al. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. Eur Heart J 2021; 42: 4638-4651. PMID: 34002203 146. Whitney SN, McGuire AL, McCullough LB. A typology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54-59. PMID: 14706973 147. Spertus JA, Salisbury AC, Jones PG, et al. Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation 2004; 110: 3789-3794. PMID: 15596563 148. Steg PG, Greenlaw N, Tendera M, et al. Prospective Observational

Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: Data from the Inter-